UK markets closed

Kanabo Group Plc (KNB.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
3.3500+0.0500 (+1.52%)
At close: 04:28PM BST

Kanabo Group Plc

Churchill House
137-139 Brent Street
London NW4 4DJ
United Kingdom

https://www.kanabogroup.com

Sector(s)Healthcare
IndustryPharmaceutical Retailers
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Avihu TamirCEO & Exec. DirectorN/AN/A1981
Mr. David SackCo-founderN/AN/AN/A
Mr. Assaf VardimonChief Financial OfficerN/AN/A1978
Howard RubensteinCompany Sec.N/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Kanabo Group Plc develops and distributes cannabis-derived products for medical patients. It also offers non- tetrahydrocannabinol products for cannabidiol consumers. The company offers its products under the Kanabo brand name. Kanabo Group Plc was founded in 2016 and is based in London, the United Kingdom. Kanabo Group Plc is a subsidiary of Altshuler Shaham Trusts Ltd.

Corporate governance

Kanabo Group Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.